The Role of Biopsy in the Assessment of Uveal Melanoma
By: Mary E. Aronow, MD; Charles V. Biscotti, MD; Chan Chi-Chao, MD; Arun D. Singh, MD
CATT: Beyond Visual Acuity
By: Frank Celia, Contributing Editor
Year 2 results did much more than just confirm that the two rival drugs are equivalent.
CATT, Meet IVAN
By: Andrew Lotery, MD
What have we learned from the ongoing
ranibizumab vs bevacizumab trials?
Controversies in Endophthalmitis Management
By: Raj R. Rathod, MD; William F. Mieler, M.D.
Do the EVS guidelines still hold up in 2012?
The Bumpy Road to (EMR) Love
By: Michael Engelbert, MD, PhD
Our chronicle of one practice’s EMR adoption.
Radiation Therapy in the Treatment of Exudative AMD
By: Darius M. Moshfeghi, MD
Epimacular brachytherapy is still alive, and X-ray irradiation may provide yet another radiation modality for AMD.
RPS: From the Podium to the Practice
By: Andrew E. Mathis, PhD, Medical Editor
The first in a series of articles covering the
2012 Retinal Physician Symposium.
Upfront: From the Editor-in-Chief
By: Peter K. Kaiser, M.D.
Playing the numbers
Higher Lucentis dose in DME; Retinal adhesion may be key to CNV; Pain-relief after intravitreal injection; and more
By: Steve Charles, MD, FACS, FICS
Considering hemostasis, retinopexy and PRP
By: Riva Lee Asbell
Using the eye codes for retina exams
By: Robert Murphy, Contributing Editor
This practice rotates around its axis